HMPV is spreading in China but there's no need to worry
Respiratory illness is common in winter
Cases of the human metapneumovirus (HMPV) are on the rise in China, causing global concern. The respiratory virus is not new, but much of the public was previously unaware of its existence. Experts say the disease is likely not going to be the next pandemic and the worry is a result of heightened wariness for respiratory illness in a post-Covid world.
What is HMPV?
HMPV is a respiratory virus that regularly circulates during cold and flu season. It is spread through coughing, sneezing and coming into contact with contaminated surfaces. It presents as common cold symptoms including cough, fever, shortness of breath and congestion. While not deadly, in some instances, cases can be more severe, especially in young children and the immunocompromised. They could "develop more severe disease where the lungs are affected, with wheezing, breathlessness and symptoms of croup," said the BBC. This could require hospitalization.
While China seems to have a spike in cases, its "reported levels of respiratory infections were along usual and expected rates, said a news briefing by the World Health Organization (WHO). The rise of HMPV is likely because "China underwent one of the world's most restrictive and prolonged lockdowns in response to Covid, reducing people's exposure to other viruses such as HMPV," said The Washington Post. "That created a situation where people became more susceptible during a surge," leading to "unusual cases even in young and middle-aged adults." The surge also aligns with low temperatures expected to last until March.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Should people be worried?
Experts aren't sounding the alarm just yet about HMPV. "It's not a new virus," Margaret Harris, a spokesperson for the WHO, said in the news briefing. "It was first identified in 2001. It's been in the human population for a long time. It is a common virus that circulates in winter and spring." The disease has been circulating similar to the flu, RSV and walking pneumonia. "How many times do you get sick in the winter and you have no idea what you've got?" said Jennifer Nuzzo, a professor of epidemiology and director of the Pandemic Center at the Brown University School of Public Health, to the Post. "It's a virus you'll get. You'll probably get it multiple times in your life."
HMPV is also not expected to be a global pandemic like Covid-19. The disease is well-studied and has been known for a long time. "There is broad population-level immunity to this virus globally; there was none, for Covid," said The New York Times. "A severe HMPV season can strain hospital capacity — particularly pediatric wards — but does not overwhelm medical centers." While there is no vaccine or antiviral for the disease, in most people it tends to pass on its own.
In general, "there's just this tendency post-Covid to treat every infectious disease anything as an emergency when it's not," Amesh Adalja, an infectious diseases physician and senior scholar at the Johns Hopkins Center for Health Security, said to the Post. However, while it is not expected to grow into a deadly pandemic, HMPV "should not be ignored," said virologist Connor Bamford in an opinion for The I Paper. "We must continue research into these viruses so we can better deploy interventions like vaccines, antivirals and preventative measures for known and unknown viruses in the future."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
What's next for Canada after Trudeau's resignation?
Talking Points An election. But not just yet.
By Joel Mathis, The Week US Published
-
Fast-spreading Los Angeles wildfires spark panic
Speed Read About 30,000 people were under an evacuation order as the inferno spread
By Peter Weber, The Week US Published
-
US accuses Sudan rebels of genocide, sanctions chief
Speed Read Sudan has been engaged in a bloody civil war that erupted in 2023
By Peter Weber, The Week US Published
-
Walking pneumonia cases are picking up pace
The explainer Another respiratory illness to be wary of
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
The future of fluoridated water is up for debate
The Explainer The oral benefits are watery
By Devika Rao, The Week US Published
-
Polycystic ovary syndrome: what it is, how it's treated and why it's often misunderstood
The Explainer PCOS affects millions, but there is still no cure outside of treating symptoms separately
By Theara Coleman, The Week US Published
-
The growing list of conditions weight-loss drugs could help with
The Explainer Ozempic and similar drugs have been linked to possibly helping diseases beyond diabetes and obesity. Are they miracle drugs?
By Theara Coleman, The Week US Published
-
ADHD drugs shortage: what's behind it?
The Explainer Supply chain issues and 'tripling' of prescriptions concerns GPs as problems getting medication become 'desperate'
By The Week UK Published
-
Should blood donors be paid?
The Explainer Financial rewards would help fill NHS shortfall but bring risk of contamination and exploitation, WHO warns
By The Week UK Published
-
UK gynaecological care crisis: why thousands of women are left in pain
The Explainer Waiting times have tripled over the past decade thanks to lack of prioritisation or funding for women's health
By Harriet Marsden, The Week UK Published